Biomarkers in Samples From Patients With Endometrial Cancer
- Trial number:
- NCT01199250
- Trial phase:
- N/A
- Study type:
- Observational, Biomarker
- Overall status:
- Not yet recruiting
Study start date
January, 2100
Scientific title
Specialized Program of Research Excellence (SPORE) in Endometrial Cancer
Summary
This research study is studying biomarkers in samples from patients with endometrial cancer. Studying samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Inclusion Criteria:
Samples available from one of the following:
GOG-0210Washington University School of Medicine Siteman Cancer Center
Study design
Time perspective:
Retrospective,
Conditions
Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
Other study ID numbers
GOG-8020; NCI-2011-02868; GOG-8020; CDR0000684553; GOG-8020; GOG-8020; P50CA134254; R01CA071754; R21CA133295; U10CA027469; U10CA037517
Choose trial site (1)
Gynecologic Oncology Group
1600 John F Kennedy Blvd Unit 1020, Philadelphia, PA 19103, USA